How do GLP-1 injections work
So in 2014, the FDA began approving these medications for weight loss first Saxenda (liraglutide) , then Wegovy (semaglutide) , Zepbound (tirzepatide) , and most recently, Foundayo (orforglipron)
All four also have meaningfully higher obesity rates than the general population, driven by shift work, stress, irregular meals, and aging workforces
When youre giving so much to others, it can be hard to give back to yourself, says Robin Seale, Hers Weight Loss Program customer
Neviere R, Fauvel H, Chopin C, Formstecher P, Marchetti P
Two of these have been approved for market: Novo Nordisks GCGR agonist, Glucagon, and Eli Lillys GCGR agonist, Glucagon